Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

4 Stocks To Watch: AMKR, CC, NKTR, OCLR

Published 11/08/2016, 11:23 PM
Updated 07/09/2023, 06:31 AM

The stock market had an interesting follow-through session. It was powerful. It was bullish. We’ll take a look at some of the stocks we follow that are doing well, but first let’s take a look at the indices.

Swing trade Amkor Technology Inc (NASDAQ:AMKR) continues to really move nicely. It popped, pulled back, we put a swing on it at the 7 1/2-3/4 range, and it reached a high of 11 1/2 on Tuesday. This stock continues to move up towards a target of 12 1/4. It was up 32 cents, or 2.9%, to 11.24, on 1.5 million shares traded. It has 31/2 days to cover .

The Chemours Co (NYSE:CC) has a great-looking chart. It had a swing put on it around the 8.00 zone, it ran up to around 11, pulled down in a 3-wave corrective low, and from that level at 5 3/4, it literally more than quadrupled. On Tuesday, it was up 81 cents, or 4.2%, to 20.09, reaching a high of 20.23, on 5.8 million shares traded. Momentum has taken it out with a breakaway gap, and on additional upside momentum, I’m looking for 22-23 short-term.

Nektar Therapeutics (NASDAQ:NKTR) is not as strong looking, but I was impressed on Tuesday with the action, up 27 cents, or 2%, to 1307, on 1.6 million shares traded, and it closed near at the upper end of the range. This is an 8-9-day high. I would like to see it run up towards 13.75-.80. That’s resistance. If it gets through that, we'll break through the declining topsline, and moving average as well. So, that’s a key level for this stock. My ultimate target and swing trade on this one is going to be 16.00.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Oclaro Inc (NASDAQ:OCLR) was up 28 cents, or 3.3%, to 8.77, on 5.7 million shares traded on Tuesday. It popped through resistance and crossed the declining topsline, and closed near the upper end of the range. I’m looking for a test of the 9 1/4 range. 9.25-.35 is resistance. If it gets through that, the next target is 10.85-11.00.

Stocks on the long side included Amkor Technology, Inc. (AMKR), AMAG Pharmaceuticals Inc (NASDAQ:AMAG), AveXis Inc (NASDAQ:AVXS), BHP Billiton Ltd (NYSE:BHP) Cara Therapeutic (NASDAQ:CARA), Cannabis Sativa Inc (OTC:CBDS), The Chemours Company (CC), VelocityShares 3x Inv Natural Gas ETN (NYSE:DGAZ), Freeport-McMoRan Inc. (NYSE:FCX), Hecla Mining Co. (NYSE:HL), MINDBODY, Inc. (NASDAQ:MB), Microchip Technology Inc. (NASDAQ:MCHP), MGM Resorts International (NYSE:MGM), Mimecast Limited (NASDAQ:MIME), Nektar Therapeutics (NASDAQ:NKTR), Oclaro, Inc. (OCLR), The Priceline Group Inc. (NASDAQ:PCLN), Synchronoss Technologies, Inc. (NASDAQ:SNCR), SodaStream International Ltd. (NASDAQ:SODA), Smith & Wesson Holding Corporation (NASDAQ:SWHC), Canopy Growth Corporation (TWMJF), and Vale S.A. (NYSE:VALE).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.